Ultragenyx Pharmaceutical Inc. (RARE) Social Stream



Ultragenyx Pharmaceutical Inc. (RARE): $39.60

1.58 (+4.16%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add RARE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#104 of 347

in industry

ULTRAGENYX PHARMACEUTICAL INC (RARE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RARE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-05 16 $185 $73 $146.2 $46.15 216.79%
2022-01-11 16 $185 $73 $143.933 $46.15 211.88%
2022-01-25 16 $185 $73 $143 $46.15 209.86%
2022-01-26 16 $185 $73 $142.4 $46.15 208.56%
2022-01-31 16 $185 $73 $140 $46.15 203.36%
2022-02-11 16 $185 $73 $140 $46.15 203.36%
2022-02-14 15 $185 $73 $139.466 $46.15 202.2%
2022-04-26 15 $186 $73 $139.533 $46.15 202.35%
2022-04-28 15 $186 $73 $139.666 $46.15 202.63%
2022-05-05 15 $186 $73 $138.461 $46.15 200.02%
2022-05-09 13 $186 $71 $129.538 $46.15 180.69%
2022-05-18 14 $186 $71 $126.846 $46.15 174.86%
2022-05-24 14 $186 $71 $125 $46.15 170.86%
2022-07-28 13 $185 $70 $121.5 $46.15 163.27%
2022-08-01 14 $185 $68 $117 $46.15 153.52%
2022-08-02 14 $185 $60 $112.666 $46.15 144.13%
2022-08-13 14 $185 $60 $114.5 $46.15 148.1%
2022-09-17 12 $185 $60 $117.266 $46.15 154.1%
2022-10-12 11 $185 $60 $117.266 $46.15 154.1%
2022-10-21 13 $185 $50 $112 $46.15 142.69%
2022-10-25 13 $185 $50 $111.5 $46.15 141.6%
2022-11-03 14 $164 $49 $102.312 $46.15 121.69%
2022-11-04 14 $143 $49 $101 $46.15 118.85%
2022-12-07 14 $143 $49 $98.125 $46.15 112.62%
2022-12-13 14 $143 $49 $94.937 $46.15 105.71%
2023-01-13 15 $143 $49 $94.176 $46.15 104.07%
2023-01-26 15 $143 $48 $94.117 $46.15 103.94%
2023-01-27 15 $143 $48 $92.823 $46.15 101.13%
2023-02-01 15 $143 $48 $92.823 $46.15 101.13%
2023-02-16 15 $143 $48 $92.529 $46.15 100.5%
2023-02-21 15 $142 $47 $91.823 $46.15 98.97%
2023-04-17 15 $142 $47 $91.588 $46.15 98.46%
2023-04-24 15 $142 $47 $91.47 $46.15 98.2%
2023-05-05 16 $142 $47 $92.722 $46.15 100.91%
2023-05-08 16 $142 $48 $91.888 $46.15 99.11%
2023-05-11 16 $142 $48 $91.777 $46.15 98.87%
2023-05-23 16 $142 $48 $92 $46.15 99.35%
2023-06-06 17 $142 $50 $93.277 $46.15 102.12%
2023-06-28 17 $140 $50 $92.777 $46.15 101.03%
2023-07-24 17 $140 $49 $92.666 $46.15 100.79%
2023-08-04 17 $140 $49 $91.941 $46.15 99.22%
2023-08-07 17 $140 $47 $91.352 $46.15 97.95%
2023-09-26 17 $140 $47 $91.588 $46.15 98.46%
2023-10-12 17 $140 $47 $91.294 $46.15 97.82%
2023-10-17 16 $140 $47 $91.294 $46.15 97.82%
2023-10-23 17 $140 $43 $92.444 $46.15 100.31%
2023-11-03 17 $140 $43 $92.611 $46.15 100.67%
2023-11-06 17 $140 $43 $91.888 $46.15 99.11%
2023-11-24 17 $140 $43 $91.777 $46.15 98.87%
2023-12-04 17 $140 $43 $91.388 $46.15 98.02%
2023-12-08 18 $140 $43 $90.368 $46.15 95.81%
2023-12-19 18 $140 $43 $89.631 $46.15 94.22%

The Trend in the Analyst Price Target


RARE's average price target has moved down $27.64 over the prior 16 months.

Over the past 49 weeks, RARE's average upside potential has been 122.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 15 143 48 92.823 43.72 112.31%
2023-02-27 15 142 47 91.588 43.46 110.74%
2023-06-06 17 142 48 92.000 51.48 78.71%
2023-06-28 17 140 50 92.777 48.01 93.25%
2023-07-24 17 140 49 92.666 42.12 120%

RARE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.22 16 0 2 0 0 18

The Trend in the Broker Recommendations


Over the past 41 months, RARE's average broker recommendation rating improved by 0.28.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how ULTRAGENYX PHARMACEUTICAL INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -4987.33% of that group.
  • In the context of stocks in the large market cap category, ULTRAGENYX PHARMACEUTICAL INC's upside potential (average analyst target price relative to current price) is greater than 5329.1% of them.
  • ULTRAGENYX PHARMACEUTICAL INC's number of analysts covering the stock is higher than 5059.6% of Pharmaceutical Products stocks.
  • ULTRAGENYX PHARMACEUTICAL INC's average analyst price target is higher than 4989.36% of Pharmaceutical Products stocks.

Stocks similar to ULTRAGENYX PHARMACEUTICAL INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CTLT, TEVA, and PRGO.

Is RARE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!